Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 277

1.

Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage.

Costa A, Facchini G, Pinheiro AL, da Silva MS, Bonner MY, Arbiser J, Eberlin S.

Int J Dermatol. 2017 Feb 22. doi: 10.1111/ijd.13569. [Epub ahead of print]

PMID:
28229451
2.

Antineoplastic Effects of Honokiol on Melanoma.

Guillermo-Lagae R, Santha S, Thomas M, Zoelle E, Stevens J, Kaushik RS, Dwivedi C.

Biomed Res Int. 2017;2017:5496398. doi: 10.1155/2017/5496398.

3.

Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells.

Gowda AS, Suo Z, Spratt TE.

Chem Res Toxicol. 2017 Feb 20;30(2):715-725. doi: 10.1021/acs.chemrestox.6b00451.

PMID:
28067485
4.

Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.

Lu CH, Chen SH, Chang YS, Liu YW, Wu JY, Lim YP, Yu HI, Lee YR.

Pharmacol Res. 2017 Jan;115:288-298. doi: 10.1016/j.phrs.2016.11.038.

PMID:
27940017
5.

Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways.

Yang J, Pei H, Luo H, Fu A, Yang H, Hu J, Zhao C, Chai L, Chen X, Shao X, Wang C, Wu W, Wan L, Ye H, Qiu Q, Peng A, Wei Y, Yang L, Chen L.

Oncotarget. 2017 Jan 3;8(1):915-932. doi: 10.18632/oncotarget.13687.

6.

Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer.

Katiyar SK.

Molecules. 2016 Nov 24;21(12). pii: E1610. Review.

7.

Sample injection strategy to increase throughput in counter-current chromatography: Case study of Honokiol purification.

Peng A, Hewitson P, Ye H, Zu L, Garrard I, Sutherland I, Chen L, Ignatova S.

J Chromatogr A. 2016 Dec 9;1476:19-24. doi: 10.1016/j.chroma.2016.10.040.

PMID:
27884427
8.

Mitochondrial dysfunction in cancer chemoprevention by phytochemicals from dietary and medicinal plants.

Sehrawat A, Roy R, Pore SK, Hahm ER, Samanta SK, Singh KB, Kim SH, Singh K, Singh SV.

Semin Cancer Biol. 2016 Nov 17. pii: S1044-579X(16)30078-5. doi: 10.1016/j.semcancer.2016.11.009. [Epub ahead of print] Review.

PMID:
27867044
9.

Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.

Pan J, Lee Y, Zhang Q, Xiong D, Wan TC, Wang Y, You M.

Cancer Prev Res (Phila). 2017 Feb;10(2):133-141. doi: 10.1158/1940-6207.CAPR-16-0129.

PMID:
27849557
10.

Qingchangligan Formula Attenuates the Inflammatory Response to Protect the Liver from Acute Failure Induced by D-galactosamine/ Lipopolysaccharide in Mice.

Zhang X, Ding J, Gou C, Wen T, Li L, Wang X, Yang H, Liu D, Lou J, Chen D, Ren F, Li X.

J Ethnopharmacol. 2016 Nov 7. pii: S0378-8741(16)31734-2. doi: 10.1016/j.jep.2016.11.007. [Epub ahead of print]

11.
12.

SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis.

Akamata K, Wei J, Bhattacharyya M, Cheresh P, Bonner MY, Arbiser JL, Raparia K, Gupta MP, Kamp DW, Varga J.

Oncotarget. 2016 Oct 25;7(43):69321-69336. doi: 10.18632/oncotarget.12504.

13.
14.

Honokiol inhibits migration of renal cell carcinoma through activation of RhoA/ROCK/MLC signaling pathway.

Cheng S, Castillo V, Welty M, Eliaz I, Sliva D.

Int J Oncol. 2016 Oct;49(4):1525-1530. doi: 10.3892/ijo.2016.3663.

PMID:
27633759
15.

Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.

Averett C, Bhardwaj A, Arora S, Srivastava SK, Khan MA, Ahmad A, Singh S, Carter JE, Khushman M, Singh AP.

Carcinogenesis. 2016 Sep 8. pii: bgw096. [Epub ahead of print]

PMID:
27609457
16.

Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.

Lv XQ, Qiao XR, Su L, Chen SZ.

Acta Pharmacol Sin. 2016 Dec;37(12):1574-1586. doi: 10.1038/aps.2016.81.

18.

Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies.

Mędra A, Witkowska M, Majchrzak A, Cebula-Obrzut B, Bonner MY, Robak T, Arbiser JL, Smolewski P.

Molecules. 2016 Jul 30;21(8). pii: E995. doi: 10.3390/molecules21080995.

19.

Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.

Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F.

Oncotarget. 2016 Sep 6;7(36):57752-57769. doi: 10.18632/oncotarget.10759.

20.

c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.

Hahm ER, Singh KB, Singh SV.

Cell Cycle. 2016 Sep;15(17):2309-20. doi: 10.1080/15384101.2016.1201253.

PMID:
27341160
Items per page

Supplemental Content

Loading ...
Support Center